Functional characterization of Kaposi's sarcoma-associated herpesvirus open reading frame K8 by bacterial artificial chromosome-based mutagenesis

Journal of Virology

Volumn 85, Issue 5, 2011, Pages 1943-1957

  Wang, Yan ^a,b   Sathish, Narayanan ^a   Hollow, Charles ^a   Yuan, Yan ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; BUTYRIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE;

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; BASIC LEUCINE ZIPPER MOTIF; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA REPLICATION; ENDOTHELIUM; GENE EXPRESSION; GENOME; HERPES VIRUS; HUMAN; HUMAN CELL; KAPOSI SARCOMA; LATENT VIRUS INFECTION; LIFE CYCLE; MICROVASCULATURE; MUTAGENESIS; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN BINDING; VIRAL GENETICS; VIRUS CELL TRANSFORMATION; VIRUS GENOME; VIRUS RECOMBINANT; VIRUS REPLICATION; WILD TYPE;

BASE SEQUENCE; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL LINE; CHROMOSOMES, ARTIFICIAL, BACTERIAL; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS; OPEN READING FRAMES; VIRAL PROTEINS; VIRUS REPLICATION;

BACTERIA (MICROORGANISMS); HUMAN HERPESVIRUS 8;

EID: 79551706206     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02060-10     Document Type: Article

References (35)

1. AuCoin, D. P., et al. 2004. Amplification of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 lytic origin of DNA replication is dependent upon a cis-acting AT-rich region and an ORF50 response element and the trans-acting factors ORF50 (K-Rta) and K8 (K-bZIP). Virology 318: 542-555.
2. Bechtel, J. T., R. C. Winant, and D. Ganem. 2005. Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus. J. Virol. 79:4952-4964. (Pubitemid 40464246)
3. Cesarman, E., E. A. Mesri, and M. C. Gershengorn. 2000. Viral G protein-coupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia? J. Exp. Med. 191:417-422.
4. Cayrol, C., and E. K. Flemington. 1996. The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. EMBO J. 15:2748-2759.
5. Fixman, E. D., G. S. Hayward, and S. D. Hayward. 1995. Replication of Epstein-Barr virus oriLyt: lack of a dedicated virally encoded origin-binding protein and dependence on Zta in cotransfection assays. J. Virol. 69:2998-3006.
6. Gardella, T., P. Medveczky, T. Sairenji, and C. Mulder. 1984. Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis. J. Virol. 50:248-254. (Pubitemid 14165314)
7. Ganem, D. 2007. Kaposi's sarcoma-associated herpesvirus, p. 2847-2888. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 5th ed. Lippincott/The Williams & Wilkins, Philadelphia, PA.
8. Gay, P., D. Le Coq, M. Steinmetz, E. Ferrari, and J. A. Hoch. 1983. Cloning structural gene sacB, which codes for exoenzyme levansucrase of Bacillus subtilis: expression of the gene in Escherichia coli. J. Bacteriol. 153:1424-1431.
9. Grundhoff, A., and D. Ganem. 2004. Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J. Clin. Invest. 113:124-136.
10. Izumiya, Y., et al. 2003. Kaposi's sarcoma-associated herpesvirus K-bZIP is a coregulator of K-Rta: physical association and promoter-dependent transcriptional repression. J. Virol. 77:1441-1451. (Pubitemid 36055565)
11. Izumiya, Y., et al. 2005. Kaposi's sarcoma-associated herpesvirus K-bZIP represses gene transcription via SUMO modification. J. Virol. 79:9912-9925. (Pubitemid 41022333)
12. Kato-Noah, T., et al. 2007. Overexpression of the Kaposi's sarcoma-associated herpesvirus transactivator K-Rta can complement a K-bZIP deletion bacmid and yields an enhanced growth phenotype. J. Virol. 81:13519-13532. (Pubitemid 350247846)
13. Krishnan, H. H., et al. 2004. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J. Virol. 78:3601-3620. (Pubitemid 38568301)
14. Kuang, E., Q. Tang, G. G. Maul, and F. Zhu. 2008. Activation of p90 ribosomal S6 kinase by ORF45 of Kaposi's sarcoma-associated herpesvirus and its role in viral lytic replication. J. Virol. 82:1838-1850. (Pubitemid 351206932)
15. Lee, E. C., et al. 2001. A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73:56-65.
16. Liao, W., Y. Tang, S. F. Lin, H. J. Kung, and C. Z. Giam. 2003. K-bZIP of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 (KSHV/HHV-8) binds KSHV/HHV-8 Rta and represses Rta-mediated transactivation. J. Virol. 77:3809-3815.
17. Lin, C. L., et al. 2003. Kaposi's sarcoma-associated herpesvirus Ori-Lyt-dependent DNA replication: identification of the Ori-Lyt and association of K8 bZIP protein with the origin. J. Virol. 77:5578-5588. (Pubitemid 36538950)
18. Lin, S.-F., D. R. Robinson, G. Miller, and H.-J. Kung. 1999. Kaposi's sarcoma-associated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein-Barr virus. J. Virol. 73:1909-1917. (Pubitemid 29098092)
19. Lukac, D. M., R. Renne, J. R. Kirshner, and D. Ganem. 1998. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 252:304-312. (Pubitemid 29013411)
20. Matsumura, S., Y. Fujita, E. Gomez, N. Tanese, and A. C. Wilson. 2005. Activation of the Kaposi's sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50). J. Virol. 79:8493-8505.
21. Miller, G. 1990. The switch between latency and replication of Epstein-Barr virus. J. Infect. Dis. 161:833-844.
22. Rossetto, C., I. Yamboliev, and G. S. Pari. 2009. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 K-bZIP modulates latency-associated nuclear protein-mediated suppression of lytic origin-dependent DNA synthesis. J. Virol. 83:9567-9576.
23. Sun, R., et al. 1998. A viral gene that activates lytic cycle expression of Kaposi's sarcoma associated herpesvirus. Proc. Natl. Acad. Sci. U. S. A. 95:10866-10871.
24. Wang, Y., O. T. Chong, and Y. Yuan. 2004. Differential regulation of K8 gene expression in immediate-early and delayed-early stages of Kaposi's sarcoma-associated herpesvirus. Virology 325:149-163. (Pubitemid 38844778)
25. Wang, Y., et al. 2004. Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: cis-acting requirements for replication and ori-Lyt-associated RNA transcription. J. Virol. 78:8615-8629. (Pubitemid 39025128)
26. Wang, Y., H. Li, Q. Tang, G. G. Maul, and Y. Yuan. 2008. Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: involvement of host cellular factors. J. Virol. 82:2867-2882.
27. Wang, Y., Q. Tang, G. G. Maul, and Y. Yuan. 2006. Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: dual role of replication and transcription activator. J. Virol. 80:12171-12186.
28. Wu, F. Y., et al. 2001. Origin-independent assembly of Kaposi's sarcoma-associated herpesvirus DNA replication compartments in transient cotransfection assays and association with the ORF-K8 protein and cellular PML. J. Virol. 75:1487-1506. (Pubitemid 32094706)
29. Wu, F. Y., et al. 2003. Cell cycle arrest by Kaposi's sarcoma-associated herpesvirus replication-associated protein is mediated at both the transcriptional and posttranslational levels by binding to CCAAT/enhancer- binding protein and p21CIP-1. J. Virol. 77:8893-8914. (Pubitemid 36936100)
30. Zhou, F. C., et al. 2002. Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis. J. Virol. 76:6185-6196.
31. Zhu, F. X., J. M. Chong, L. Wu, and Y. Yuan. 2005. Virion proteins of Kaposi's sarcoma-associated herpesvirus. J. Virol. 79:800-811. (Pubitemid 40053863)
32. Zhu, F. X., T. Cusano, and Y. Yuan. 1999. Identification of the immediateearly transcripts of Kaposi's sarcoma-associated herpesvirus. J. Virol. 73: 5556-5567. (Pubitemid 29274839)
33. Zhu, F. X., S. M. King, E. J. Smith, D. E. Levy, and Y. Yuan. 2002. A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation. Proc. Natl. Acad. Sci. U. S. A. 99:5573-5578.
34. Zhu, F. X., N. N. Sathish, and Y. Yuan. 2010. Antagonism of host antiviral responses by Kaposi's sarcoma-associated herpesvirus tegument protein ORF45. PLoS One 5:e10573.
35. Zhu, F. X., X. Li, F. Zhou, S. J. Gao, and Y. Yuan. 2006. Functional characterization of Kaposi's sarcoma-associated herpesvirus ORF45 by bacterial artificial chromosome-based mutagenesis. J. Virol. 80:12187-12196. (Pubitemid 44904369)